BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 13678295)

  • 1. Recombinant glutamate carboxypeptidase II (prostate specific membrane antigen--PSMA)--cellular localization and bioactivity analyses.
    Meighan MA; Dickerson MT; Glinskii O; Glinsky VV; Wright GL; Deutscher SL
    J Protein Chem; 2003 May; 22(4):317-26. PubMed ID: 13678295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cloning and characterization of canine prostate-specific membrane antigen.
    Schmidt S; Fracasso G; Colombatti M; Naim HY
    Prostate; 2013 May; 73(6):642-50. PubMed ID: 23359458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The homodimer of prostate-specific membrane antigen is a functional target for cancer therapy.
    Schülke N; Varlamova OA; Donovan GP; Ma D; Gardner JP; Morrissey DM; Arrigale RR; Zhan C; Chodera AJ; Surowitz KG; Maddon PJ; Heston WD; Olson WC
    Proc Natl Acad Sci U S A; 2003 Oct; 100(22):12590-5. PubMed ID: 14583590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunological response of mice induced by recombinant adenovirus carrying rat prostate-specific membrane antigen gene].
    Wang SJ; Zhang DM; Yang L
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Mar; 42(2):147-51. PubMed ID: 21500542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of a baculovirus recombinant prostate-specific membrane antigen and its use in the development of a novel protein biochip quantitative immunoassay.
    Xiao Z; Jiang X; Beckett ML; Wright GL
    Protein Expr Purif; 2000 Jun; 19(1):12-21. PubMed ID: 10833385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the N-glycosylation sites on glutamate carboxypeptidase II necessary for proteolytic activity.
    Barinka C; Sácha P; Sklenár J; Man P; Bezouska K; Slusher BS; Konvalinka J
    Protein Sci; 2004 Jun; 13(6):1627-35. PubMed ID: 15152093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel regulation of PSMA and PSA expression by Q640X AR in 22Rv1 and LNCaP prostate cancer cells.
    Ben Jemaa A; Sallami S; Céraline J; Oueslati R
    Cell Biol Int; 2013 May; 37(5):464-70. PubMed ID: 23418075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disulfide-constrained peptides that bind to the extracellular portion of the prostate-specific membrane antigen.
    Lupold SE; Rodriguez R
    Mol Cancer Ther; 2004 May; 3(5):597-603. PubMed ID: 15141017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different glycoforms of prostate-specific membrane antigen are intracellularly transported through their association with distinct detergent-resistant membranes.
    Castelletti D; Alfalah M; Heine M; Hein Z; Schmitte R; Fracasso G; Colombatti M; Naim HY
    Biochem J; 2008 Jan; 409(1):149-57. PubMed ID: 17935484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient and versatile one-step affinity purification of in vivo biotinylated proteins: expression, characterization and structure analysis of recombinant human glutamate carboxypeptidase II.
    Tykvart J; Sácha P; Bařinka C; Knedlík T; Starková J; Lubkowski J; Konvalinka J
    Protein Expr Purif; 2012 Mar; 82(1):106-15. PubMed ID: 22178733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New alternatively spliced variant of prostate-specific membrane antigen PSM-E suppresses the proliferation, migration and invasiveness of prostate cancer cells.
    Cao KY; Xu L; Zhang DM; Zhang XM; Zhang T; He X; Wang Z; Feng FS; Qiu SP; Shen GX
    Int J Oncol; 2012 Jun; 40(6):1977-85. PubMed ID: 22322627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate specific membrane antigen knockdown impairs the tumorigenicity of LNCaP prostate cancer cells by inhibiting the phosphatidylinositol 3-kinase/Akt signaling pathway.
    Guo Z; Lai Y; Du T; Zhang Y; Chen J; Bi L; Lin T; Liu H; Wang W; Xu K; Jiang C; Han J; Zhang C; Dong W; Huang J; Huang H
    Chin Med J (Engl); 2014; 127(5):929-36. PubMed ID: 24571890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of prostate-specific membrane antigen (PSMA)-positive tumor growth by vaccination with either full-length or the C-terminal end of PSMA.
    Kuratsukuri K; Sone T; Wang CY; Nishisaka N; Jones RF; Haas GP
    Int J Cancer; 2002 Nov; 102(3):244-9. PubMed ID: 12397643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PSMA-homing dsRNA chimeric protein vector kills prostate cancer cells and activates anti-tumor bystander responses.
    Langut Y; Edinger N; Flashner-Abramson E; Melamed-Book N; Lebendiker M; Levi-Kalisman Y; Klein S; Levitzki A
    Oncotarget; 2017 Apr; 8(15):24046-24062. PubMed ID: 28445962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel cytoplasmic tail MXXXL motif mediates the internalization of prostate-specific membrane antigen.
    Rajasekaran SA; Anilkumar G; Oshima E; Bowie JU; Liu H; Heston W; Bander NH; Rajasekaran AK
    Mol Biol Cell; 2003 Dec; 14(12):4835-45. PubMed ID: 14528023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MRI Assessment of Prostate-Specific Membrane Antigen (PSMA) Targeting by a PSMA-Targeted Magnetic Nanoparticle: Potential for Image-Guided Therapy.
    Ngen EJ; Benham Azad B; Boinapally S; Lisok A; Brummet M; Jacob D; Pomper MG; Banerjee SR
    Mol Pharm; 2019 May; 16(5):2060-2068. PubMed ID: 30912947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of methotrexate-based peptide substrates to characterize the substrate specificity of prostate-specific membrane antigen (PSMA).
    Mhaka A; Gady AM; Rosen DM; Lo KM; Gillies SD; Denmeade SR
    Cancer Biol Ther; 2004 Jun; 3(6):551-8. PubMed ID: 15044850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The construction of recombinant plasmid with prostate-specific membrane antigen promoter controlling reporter gene expression].
    Zeng H; Li H; Liao YC; Li X; Wu Q; Yang YR
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Mar; 36(2):169-71. PubMed ID: 15807257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal structure of prostate-specific membrane antigen, a tumor marker and peptidase.
    Davis MI; Bennett MJ; Thomas LM; Bjorkman PJ
    Proc Natl Acad Sci U S A; 2005 Apr; 102(17):5981-6. PubMed ID: 15837926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of prostate specific membrane antigen by canine hemangiosarcoma cells provides opportunity for the molecular detection of disease burdens within hemorrhagic body cavity effusions.
    Dowling M; Samuelson J; Fadl-Alla B; Pondenis HC; Byrum M; Barger AM; Fan TM
    PLoS One; 2019; 14(1):e0210297. PubMed ID: 30601866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.